Stay updated with breaking news from Bruton Shepard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.
Some insurers are bypassing hospital pharmacies and physician offices and instead sending more complex drugs through third-party pharmacies, which shifts who gets to buy and bill for these complex medications, including pricey chemotherapy drugs.
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients.
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country. The issue